• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RKIP表达的降低通过激活Stat3信号通路促进鼻咽癌的侵袭和转移。

Reduction of RKIP expression promotes nasopharyngeal carcinoma invasion and metastasis by activating Stat3 signaling.

作者信息

He Qiu-Yan, Yi Hong-Mei, Yi Hong, Xiao Ta, Qu Jia-Quan, Yuan Li, Zhu Jin-Feng, Li Jiao-Yang, Wang Yuan-Yuan, Li Li-Na, Feng Juan, Lu Shan-Shan, Xiao Zhi-Qiang

机构信息

Research Center of Carcinogenesis and Targeted Therapy, Xiangya Hospital, Central South University, Changsha, Hunan, China.

The Higher Educational Key Laboratory for Cancer Proteomics and Translational Medicine of Hunan Province, Xiangya Hospital, Central South University, Changsha, Hunan, China.

出版信息

Oncotarget. 2015 Jun 30;6(18):16422-36. doi: 10.18632/oncotarget.3847.

DOI:10.18632/oncotarget.3847
PMID:25915430
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4599279/
Abstract

The role and underlying mechanism of Raf kinase inhibitory protein (RKIP) in nasopharyngeal carcinoma (NPC) metastasis remain unclear. Here, we showed that RKIP was downregulated in the NPC with high metastatic potentials, and its decrement correlated with NPC metastasis and poor patient survival, and was an independent predictor for reduced overall survival. With a combination of loss-of-function and gain-of-function approaches, we observed that high expression of RKIP reduced invasion, metastasis and epithelial to mesenchymal transition (EMT) marker alternations of NPC cells. We further showed that RKIP overexpression attenuated while RKIP knockdown enhanced Stat3 phosphorylation and activation in NPC cells; RKIP reduced Stat3 phosphorylation through interacting with Stat3; Stattic attenuated NPC cell migration, invasion and EMT marker alternations induced by RKIP knockdown, whereas Stat3 overexpression restored NPC cell migration, invasion and EMT marker alternations reduced by RKIP overexpression. In addition, there was an inverse correlation between RKIP and phospho-Stat3 expression in the NPC tissues and xenograft metastases. Our data demonstrate that RKIP is a metastatic suppressor and predictor for metastasis and prognosis in NPC, and RKIP downregulation promotes NPC invasion, metastasis and EMT by activating Stat3 signaling, suggesting that RKIP/Stat3 signaling could be used as a therapeutic target for NPC metastasis.

摘要

Raf激酶抑制蛋白(RKIP)在鼻咽癌(NPC)转移中的作用及潜在机制尚不清楚。在此,我们发现RKIP在具有高转移潜能的NPC中表达下调,其减少与NPC转移及患者预后不良相关,且是总生存期降低的独立预测因子。通过功能缺失和功能获得方法相结合,我们观察到RKIP高表达降低了NPC细胞的侵袭、转移及上皮-间质转化(EMT)标志物变化。我们进一步表明,RKIP过表达减弱而RKIP敲低增强了NPC细胞中Stat3的磷酸化和激活;RKIP通过与Stat3相互作用降低Stat3磷酸化;Stattic减弱了RKIP敲低诱导的NPC细胞迁移、侵袭及EMT标志物变化,而Stat3过表达恢复了RKIP过表达降低的NPC细胞迁移、侵袭及EMT标志物变化。此外,在NPC组织和异种移植转移灶中,RKIP与磷酸化Stat3表达呈负相关。我们的数据表明,RKIP是NPC转移及转移和预后的抑制因子及预测因子,RKIP下调通过激活Stat3信号促进NPC侵袭、转移和EMT,提示RKIP/Stat3信号可作为NPC转移的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afd5/4599279/2792a1cf4c04/oncotarget-06-16422-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afd5/4599279/741e782a4d83/oncotarget-06-16422-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afd5/4599279/394da8c2526d/oncotarget-06-16422-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afd5/4599279/98dafedc3f7e/oncotarget-06-16422-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afd5/4599279/687bf466ccdc/oncotarget-06-16422-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afd5/4599279/2792a1cf4c04/oncotarget-06-16422-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afd5/4599279/741e782a4d83/oncotarget-06-16422-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afd5/4599279/394da8c2526d/oncotarget-06-16422-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afd5/4599279/98dafedc3f7e/oncotarget-06-16422-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afd5/4599279/687bf466ccdc/oncotarget-06-16422-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afd5/4599279/2792a1cf4c04/oncotarget-06-16422-g005.jpg

相似文献

1
Reduction of RKIP expression promotes nasopharyngeal carcinoma invasion and metastasis by activating Stat3 signaling.RKIP表达的降低通过激活Stat3信号通路促进鼻咽癌的侵袭和转移。
Oncotarget. 2015 Jun 30;6(18):16422-36. doi: 10.18632/oncotarget.3847.
2
Identification of RKIP as an invasion suppressor protein in nasopharyngeal carcinoma by proteomic analysis.通过蛋白质组学分析鉴定RKIP作为鼻咽癌中的一种侵袭抑制蛋白。
J Proteome Res. 2008 Dec;7(12):5254-62. doi: 10.1021/pr800602c.
3
Deficiency of pigment epithelium-derived factor in nasopharyngeal carcinoma cells triggers the epithelial-mesenchymal transition and metastasis.鼻咽癌细胞中色素上皮衍生因子的缺乏引发上皮-间质转化和转移。
Cell Death Dis. 2017 Jun 1;8(6):e2838. doi: 10.1038/cddis.2017.114.
4
Hes1 triggers epithelial-mesenchymal transition (EMT)-like cellular marker alterations and promotes invasion and metastasis of nasopharyngeal carcinoma by activating the PTEN/AKT pathway.Hes1通过激活PTEN/AKT通路触发上皮-间质转化(EMT)样细胞标志物改变,并促进鼻咽癌的侵袭和转移。
Oncotarget. 2015 Nov 3;6(34):36713-30. doi: 10.18632/oncotarget.5457.
5
Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.Raf激酶抑制蛋白依赖性Notch1活性对上皮-间质转化和转移的调控
Oncotarget. 2016 Jan 26;7(4):4632-46. doi: 10.18632/oncotarget.6728.
6
Down-regulation of prostate stem cell antigen (PSCA) by Slug promotes metastasis in nasopharyngeal carcinoma.Slug对前列腺干细胞抗原(PSCA)的下调促进鼻咽癌转移。
J Pathol. 2015 Dec;237(4):411-22. doi: 10.1002/path.4582. Epub 2015 Aug 18.
7
Downregulating HMGA2 attenuates epithelial-mesenchymal transition-induced invasion and migration in nasopharyngeal cancer cells.下调HMGA2可减弱鼻咽癌细胞中上皮-间质转化诱导的侵袭和迁移。
Biochem Biophys Res Commun. 2015 Jul 31;463(3):357-63. doi: 10.1016/j.bbrc.2015.05.068. Epub 2015 May 27.
8
Reduced RKIP enhances nasopharyngeal carcinoma radioresistance by increasing ERK and AKT activity.RKIP表达降低通过增加ERK和AKT活性增强鼻咽癌的放射抗性。
Oncotarget. 2016 Mar 8;7(10):11463-77. doi: 10.18632/oncotarget.7201.
9
Opa interacting protein 5 promotes metastasis of nasopharyngeal carcinoma cells by promoting EMT via modulation of JAK2/STAT3 signal.Opa 相互作用蛋白 5 通过调节 JAK2/STAT3 信号促进 EMT 从而促进鼻咽癌细胞的转移。
Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):613-621. doi: 10.26355/eurrev_201901_16875.
10
c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC.c-Src激活通过PI3K/Akt信号通路诱导上皮-间质转化促进鼻咽癌转移:鼻咽癌的一个新的且有前景的靶点
Oncotarget. 2016 May 10;7(19):28340-55. doi: 10.18632/oncotarget.8634.

引用本文的文献

1
Pan-Cancer Computational Analysis of RKIP () and LKB1 () Co-Expression Highlights Distinct Immunometabolic Dynamics and Therapeutic Responses Within the Tumor Microenvironment.RKIP()和LKB1()共表达的泛癌计算分析突出了肿瘤微环境中不同的免疫代谢动态和治疗反应。
Int J Mol Sci. 2025 Jul 24;26(15):7145. doi: 10.3390/ijms26157145.
2
Bmi-1 promotes the proliferation, migration and invasion, and inhibits cell apoptosis of human retinoblastoma cells via RKIP.Bmi-1 通过 RKIP 促进人视网膜母细胞瘤细胞的增殖、迁移和侵袭,抑制细胞凋亡。
Sci Rep. 2024 Jun 24;14(1):14544. doi: 10.1038/s41598-024-65011-6.
3
Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies.

本文引用的文献

1
miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells.微小RNA-27a通过靶向人肺腺癌细胞中的RKIP来调节顺铂耐药性和转移。
Mol Cancer. 2014 Aug 16;13:193. doi: 10.1186/1476-4598-13-193.
2
RKIP suppresses gastric cancer cell proliferation and invasion and enhances apoptosis regulated by microRNA-224.RKIP抑制胃癌细胞的增殖和侵袭,并增强由微小RNA-224调控的细胞凋亡。
Tumour Biol. 2014 Oct;35(10):10095-103. doi: 10.1007/s13277-014-2303-4. Epub 2014 Jul 14.
3
EGCG inhibits the growth and tumorigenicity of nasopharyngeal tumor-initiating cells through attenuation of STAT3 activation.
靶向 RAS/RAF/MAPK 通路治疗癌症:从机制到临床研究。
Signal Transduct Target Ther. 2023 Dec 18;8(1):455. doi: 10.1038/s41392-023-01705-z.
4
Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect.鼻咽癌精准医学:过去、现在和未来展望的全面综述。
J Transl Med. 2023 Nov 6;21(1):786. doi: 10.1186/s12967-023-04673-8.
5
The Role of RKIP in the Regulation of EMT in the Tumor Microenvironment.RKIP在肿瘤微环境中上皮-间质转化调节中的作用
Cancers (Basel). 2022 Sep 22;14(19):4596. doi: 10.3390/cancers14194596.
6
The RAF Kinase Inhibitor Protein (RKIP): Good as Tumour Suppressor, Bad for the Heart.RAF 激酶抑制剂蛋白(RKIP):既是肿瘤抑制因子,也是心脏杀手。
Cells. 2022 Feb 14;11(4):654. doi: 10.3390/cells11040654.
7
Overexpression of Raf-1 kinase inhibitor protein inhibits cell invasion and migration in lung cancer cells through suppressing epithelial-mesenchymal transition.Raf-1激酶抑制蛋白的过表达通过抑制上皮-间质转化来抑制肺癌细胞的侵袭和迁移。
Transl Cancer Res. 2019 Oct;8(6):2295-2306. doi: 10.21037/tcr.2019.09.56.
8
Integrative Transcriptomic, Proteomic and Functional Analysis Reveals ATP1B3 as a Diagnostic and Potential Therapeutic Target in Hepatocellular Carcinoma.综合转录组学、蛋白质组学和功能分析揭示 ATP1B3 作为肝细胞癌的诊断和潜在治疗靶点。
Front Immunol. 2021 Apr 2;12:636614. doi: 10.3389/fimmu.2021.636614. eCollection 2021.
9
Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma.鼻咽癌靶向治疗的研究进展主要基于信号通路。
Signal Transduct Target Ther. 2020 Oct 23;5(1):245. doi: 10.1038/s41392-020-00340-2.
10
Downregulation of RKIP promotes radioresistance of nasopharyngeal carcinoma by activating NRF2/NQO1 axis via downregulating miR-450b-5p.RKIP 的下调通过下调 miR-450b-5p 来激活 NRF2/NQO1 轴,从而促进鼻咽癌的放射抵抗。
Cell Death Dis. 2020 Jul 6;11(7):504. doi: 10.1038/s41419-020-2695-6.
表没食子儿茶素没食子酸酯通过减弱信号转导与转录激活因子3(STAT3)的激活来抑制鼻咽肿瘤起始细胞的生长和致瘤性。
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2372-81. eCollection 2014.
4
STAT3 and epithelial-mesenchymal transitions in carcinomas.信号转导和转录激活因子3(STAT3)与癌症中的上皮-间质转化
JAKSTAT. 2014 Jan 1;3(1):e28975. doi: 10.4161/jkst.28975. Epub 2014 Apr 29.
5
Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancer.拉夫激酶抑制蛋白(RKIP)可阻断乳腺癌和前列腺癌中信号转导及转录激活因子3(STAT3)的激活。
PLoS One. 2014 Mar 21;9(3):e92478. doi: 10.1371/journal.pone.0092478. eCollection 2014.
6
Berberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblasts.小檗碱通过抑制肿瘤相关成纤维细胞诱导的STAT3激活来抑制鼻咽癌细胞的致瘤性和生长。
BMC Cancer. 2013 Dec 31;13:619. doi: 10.1186/1471-2407-13-619.
7
LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation.LPLUNC1通过抑制Stat3激活来抑制白细胞介素-6诱导的鼻咽癌细胞增殖。
Oncogene. 2014 Apr 17;33(16):2098-109. doi: 10.1038/onc.2013.161. Epub 2013 May 27.
8
STAT3 as a therapeutic target for Epstein-Barr virus (EBV): associated nasopharyngeal carcinoma.STAT3 作为治疗 EBV(Epstein-Barr 病毒)相关鼻咽癌的靶点。
Cancer Lett. 2013 Apr 28;330(2):141-9. doi: 10.1016/j.canlet.2012.11.052. Epub 2012 Dec 6.
9
Raf kinase inhibitor protein (RKIP) in cancer.Raf 激酶抑制剂蛋白(RKIP)在癌症中的作用。
Cancer Metastasis Rev. 2012 Dec;31(3-4):615-20. doi: 10.1007/s10555-012-9365-9.
10
Prospective study of prognostic value of Raf kinase inhibitory protein and pretreatment plasma Epstein-Barr virus DNA for distant metastasis in locoregionally advanced nasopharyngeal carcinoma.局部晚期鼻咽癌中 Raf 激酶抑制蛋白和治疗前血浆 Epstein-Barr 病毒 DNA 对远处转移的预后价值的前瞻性研究。
Head Neck. 2013 Apr;35(4):579-91. doi: 10.1002/hed.23009. Epub 2012 May 18.